Your session is about to expire
← Back to Search
Education, Physical Activity, and Stress Management Program for Cardiovascular Risk
Study Summary
This trial will test a 12-week program to help perimenopausal Latinas reduce their risk of cardiovascular disease by improving nutrition, physical activity, sleep, and stress management.
- Cardiovascular Risk
- Self-Efficacy
- Vascular Stiffness
- Physical Activity
- Health Behaviors
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is recruitment still open for this scientific experiment?
"According to clinicaltrials.gov, this medical research project has finished recruiting candidates as of July 28th 2022. It was initially posted on June 30th 2020 and is no longer accepting applicants at this time. However, there are 709 other studies actively searching for participants right now."
Does this medical experiment permit the participation of participants under 25 years of age?
"This clinical trial seeks patients aged between 40 to 60. Patients that are under 18 and over 65 can find 98 and 579 trials, respectively, best suited for their age group."
Do I qualify to take part in this investigation?
"This trial is open to 51 individuals who fit the following criteria: aged between 40 and 60, identify as Hispanic/Latina, comprehend either English or Spanish orally, perimenopausal or in early postmenopause (menses within past 3 months but irregular; no menses in last 3-11 months; last menstrual cycle 12-24 months ago), possess a uterus and at least one ovary, not expecting a child currently, abstained from hormone therapy of oral contraceptives for three prior months. Additionally they must provide consent before joining the study."
What goals are researchers seeking to accomplish with this research endeavor?
"This medical trial is seeking to measure the effect of its intervention on fasting lipids (LDL cholesterol) between baseline assessment and six months after treatment completion. Secondary objectives include changes in weight and BMI, as well as a comparison of health behaviors based on responses to a 16-item food behavior checklist."
Share this study with friends
Copy Link
Messenger